Inventor
STRAH-PLEYNET SONJA
US26 patents
⚠️ This page may combine multiple inventors who share the name “STRAH-PLEYNET SONJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
17 patentsUS7884101B2Feb 8, 2011
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC42 citations95
US9273035B2Mar 1, 2016
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC15 citations92
USRE45337EJan 13, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations92
US9732039B2Aug 15, 2017
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC17 citations91
US10632134B2Apr 28, 2020
Cannabinoid receptor modulators
ARENA PHARM INC5 citations83
US9867822B2Jan 16, 2018
Cannabinoid receptor modulators
ARENA PHARM INC7 citations83
US9492447B2Nov 15, 2016
Cannabinoid receptor modulators
ARENA PHARM INC9 citations83
US9221755B2Dec 29, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations83
US11771695B2Oct 3, 2023
Cannabinoid receptor modulators
ARENA PHARM INC4 citations74
US9775829B2Oct 3, 2017
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC4 citations73
US6420563B1Jul 16, 2002
Small molecule modulators of G protein-coupled receptor six
ARENA PHARM INC7 citations73
US11214548B2Jan 4, 2022
Cannabinoid receptor modulators
ARENA PHARM INC3 citations72
US12109219B2Oct 8, 2024
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US11746091B2Sep 5, 2023
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US10781180B2Sep 22, 2020
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
US10450276B2Oct 22, 2019
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
US10351531B2Jul 16, 2019
Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
TEEGARDEN BRADLEY
5 patentsUS8871797B2Oct 28, 2014
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
TEEGARDEN BRADLEY15 citations92
US8148418B2Apr 3, 2012
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY16 citations91
US8754238B2Jun 17, 2014
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
TEEGARDEN BRADLEY16 citations90
US8785441B2Jul 22, 2014
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY11 citations82
US8680119B2Mar 25, 2014
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY11 citations82